The characteristics of binding to the chemotactic receptors on rabbit peritoneal neutrophils were examined for seven formyl peptide analogues. These receptor-binding characteristics were compared with the abilities of the analogues to induce the biological responses of degranulation and chemotaxis. Five of the analogues showed distinct functional heterogeneity in their receptor-binding patterns, whereas the two most potent compounds displayed homogeneous binding patterns. The relative potencies of the formyl peptide analogues for stimulation of degranulation correlated well with their relative potencies for high-affinity, but not low-affinity, binding. The biphasic patterns for stimulation of chemotactic migration were similar for the less potent analogues, and their potencies paralleled those for both degranulation and receptor binding. In contrast, the most potent analogues induced a greater maximal extent of chemotactic migration than the other compounds, but displayed a lower than expected potency (i.e. they required higher than expected concentrations). 
INTRODUCTION
The neutrophil plays a major role in the body's defence mechanism against infectious micro-organisms. It responds by moving towards, engulfing and digesting such foreign pathogens. Binding of a chemotactic factor to a specific receptor on the neutrophil surface triggers the diverse repertoire of responses of this cell [1] [2] [3] [4] . Although much progress has been made towards characterizing the receptors for several chemotactic substances, particularly the formyl peptides, little is as yet known -about the differential control of the various cellular responses.
Many studies of the chemotactic formyl peptide receptors on the neutrophil have provided evidence of divergence from the simple binding pattern predicted by the Law of Mass Action for binding to a single class of similar independent receptors of fixed affinity [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . The receptor-binding pattern is thus regarded as functionally heterogeneous. Different types of studies, however, have yielded evidence of different forms of heterogeneity [5, 7, 9, 10, 13] . There is thus no consensus about the most appropriate receptor model to explain the observed binding pattern. Nor is it clear what role, if any, the functional receptor heterogeneity plays in determining the diverse biological responses of the neutrophil upon stimulation by a chemotactic factor.
The principal explanation for binding heterogeneity such as that observed is the existence of high-and low-affinity forms of the receptor. These may be interconvertible states of a single receptor [7, [15] [16] [17] , or distinct and totally independent receptor classes [5, 18] . One proposal for the neutrophil is that the highaffinity form of the receptor may be responsible for activation of some biological functions, notably chemotaxis, with the lowaffinity form responsible for other functions, e.g. degranulation [1, [19] [20] [21] . Similar proposals have been made to explain the differential activation of a range of biological responses in several other cell types and with several other receptor agonists. The only evidence to date to support this hypothesis for the neutrophil, however, is derived from studies of the influence of various perturbations of the cell on both the receptor-binding pattern and the biological responses for a single chemotactic formyl peptide, the prototypical compound N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMet-Leu-Phe).
The study described in this paper represents a different approach to test this hypothesis. Instead of manipulating the properties of the cell, the responses of intact neutrophils were examined for a series of formyl peptide analogues. The prototypical compound and six analogues of widely differing potency were tested and compared in detail for their receptor-binding patterns and abilities to stimulate degranulation and chemotaxis. The experimental data were evaluated on the basis of an independent 'two-binding-site' model for the receptors, primarily because this model is currently the only one amenable to a thorough and complete mathematical analysis. The four remaining chemotactic formyl peptides were synthesized by a rapid mixed anhydride method and purified by crystallization, as described previously [22, 23] .
Each of the non-radioactive formyl peptides showed a purity 
(fMet-Leu-Phe-Phe), of corrected specific radioactivity 21 Ci/ mmol [25] butan-l-ol/acetic acid/water (4: 1: 1, by vol.) containing 0.2 % 2-mercaptoethanol, using the procedure described previously [24] . Repurification was repeated at 3-month intervals. No repurification was necessary, however, with the purer and more stable norleucyl analogues [12] .
The quality of each radioligand was established using the methods described previously for radiolabelled fMet-Leu-Phe, including radiochemical analysis by t.l.c., assessment of receptor reactivity and bioassay [24] . The results of these quality assessments have already been published [12, 24, 25] , with the exception of the bioassay data for fNle-Leu-[3H]Phe-Tyr. The biological potency of the latter radioligand was 113 + 15 % (mean + S.E.M.; from four studies comparing the degranulation response induced by the radioligand with that induced by non-radioactive fNleLeu-Phe-Tyr). All five radioligands were thus essentially pure and equivalent to their non-radioactive counterparts; all were suitable for detailed receptor studies [24, 26] .
Rabbit neutrophils
Rabbit peritoneal neutrophils were collected 5-7 h after the injection of 300 ml of sterile shellfish glycogen (1 mg/ml) in 150 mM-NaCl, as described previously [12, 27] . Neutrophils elicited in this manner have previously proved suitable for detailed characterization of the biological responses to and receptor binding of chemotactic formyl peptide analogues [12, 22, 23] . The neutrophils were washed twice in Mg2+-free Hanks' balanced salt solution containing 1.7 mM-CaCI2 Dglucose (1 mg/ml) and 10 mM-Hepes, pH 7.2. They were resuspended in the same solution containing BSA (0.1 mg/ml) for the receptor-binding and degranulation studies, and in the same solution containing 0.7 mM-MgSO4 and BSA (0.5 mg/ml) for the chemotaxis studies.
Receptor-binding assay Binding of the various formyl peptides to the chemotactic receptors on intact rabbit neutrophils was assessed by the silicone oil assay described previously [12, 25] . In brief, the usual procedure involved the layering of 50 ,ul of formyl peptide solution (radioligand on its own or together with a non-radioactive ligand) at 4°C over 500 ,ul of Versilube F50 silicone oil (General Electric, Silicone Products Division, Waterford, NY, U.S.A.) in a microcentrifuge tube; the binding reaction was started by the careful addition of 50 ,ul of neutrophil suspension (2 x 107 cells/ ml, final concentration). Different reaction volumes (200 ,ul in total) and neutrophil concentrations (5 x 106 cells/ml), however, were used in the studies with [3H]fMet-Leu-Phe-Phe. The reaction was stopped after 15 min at 4 'C by centrifugation (13 000 g, 2 min), and the radioactive content of the cell pellet was determined by scintillation counting [12] . All binding measurements were performed in duplicate, and each binding curve comprised 14 or 15 dose points spanning an approximate 1000-fold range.
The receptor-binding studies undertaken were of two types: direct studies of the saturability of binding at equilibrium with increasing concentrations of a tritiated radioligand [12] , and indirect studies in which the binding of a non-radioactive analogue was deduced from its ability to competitively inhibit the binding of a tracer concentration (5 x 10-11 M) of f[35S]MetLeu-Phe [25] . Each study comprised a comparison of the binding characteristics of two or three of the formyl peptide analogues; fMet-Leu-Phe was always included as one of the competing ligands whenever the competitive binding approach was adopted.
For three of the formyl peptides (fMlet-Leu-Phe, fNle-Leu-Phe and fMet-Leu-Phe-Phe), studies of both types were performed and the resulting estimates of binding affinity were indistinguishable (for fMet-Leu-Phe, six direct binding studies yielded geometric mean affinity values, based on an independent twobinding-site model, of 4.9 x 10-10 and 3.7 x 10-9 M for the highand low-affinity sites respectively, whereas 18 competitive binding studies yielded values of 5.0 x 10-10 and 4.5 x 10-9 M respectively; P > 0.5 and P > 0.2, t tests after logarithmic data transformation). Only direct binding studies were performed with fNleLeu-Phe-Tyr, and only competitive binding studies with the remaining three analogues. That the incubation time (15 min) used in these studies was sufficient to allow equilibrium binding has been shown previously for both the most potent and the least potent of the radioligands [25, 28] ; the lack of any change in competitive inhibition pattern for N-formyl-L-norvalyl-L-leucyl-L-phenylalanine (fNva-Leu-Phe) when the incubation time was increased to 1 h further implied that 15 min was sufficient for equilibration even with this formyl peptide analogue (one of the least potent).
The data for all studies were analysed using the PREBIND computer program in conjunction with a version of the LIGAND program [29, 30] [15, 16] , so the quality of the fit to one particular model should not be regarded as evidence to exclude the other. On the contrary, a good fit to one model also implies a good fit to the other.
Degranulation assay
The stimulation by chemotactic formyl peptide of the release of N-acetyl-/J-D-glucosaminidase (EC 3.2.1.30) from the granules of rabbit neutrophils was assessed by the procedure described previously [24, 25] . In brief, rabbit neutrophils (5 x 10 cells/ml) were incubated for 5 min at 37°C with a series of concentrations oF formyl peptide in the presence of cytochalasin B (5 ,ug/ml).
The fi-glucosaminidase released from the cells was assayed using the chromogenic substrate p-nitrophenyl-N-acetyl-/J-D-glucosaminide. All measurements were performed in duplicate, and each dose-response curve comprised 9 or 10 dose points spanning an approximate 10000-fold range. The dose-response curves were analysed using the ENZREL computer program [24, 25] .
Chemotaxis assay
Formyl peptide stimulation of chemotaxis by rabbit neutrophils was assessed by a modification of the Boyden chamber assay [33] . Each lower well of the multi-chamber blind-well chemotaxis plate was filled with 150 ,u1 of formyl peptide solution (a series of concentrations), and 150 ,ul of neutrophil suspension (106 cells/ml) was placed above the filter (8 ,um instead, consistent with the presence of two independent classes of receptors differing in affinity (Table 1) . Consistency with this model, however, implies that the data should also be consistent with a model comprising two interconvertible states differing in affinity; these alternative models should not be regarded as mutually exclusive (see the Materials and methods and Discussion sections).
Competitive binding studies were performed with two formyl peptide analogues of lower biological potency, fNva-Leu-Phe and N-formyl-L-valyl-L-leucyl-L-phenylalanine (fVal-Leu-Phe). Each of these analogues was able to compete with f[355]MetLeu-Phe for binding to both of the postulated classes of receptors (Fig. la) . The competitive binding patterns were consistent with an independent two-binding-site model [P > 0.5 for fNva-LeuPhe and P > 0.1 for fVal-Leu-Phe; partial F test (see [25] for method of calculation)], and the calculated binding affinities for each analogue differed between the two binding sites (Table 1) .
In contrast, we have previously reported an essentially homogeneous binding pattern (consistent with a one-binding-site model) for a highly potent formyl peptide analogue, fMet-LeuPhe-Phe [25] . This conclusion was derived from both direct and competitive binding studies. A similar pattern was found in the present study for competitive binding by another very potent analogue, fMet-Leu-Phe benzylamide (fMet-Leu-Phe-NHBzl). Like fMet-Leu-Phe-Phe, this compound competed with almost Vol. 276 5 .0 % and 6.70 respectively. The lines represent the optimal fits to an independent two-binding-site model with receptors of fixed affinity, subject to the constraint that the two formyl peptides in each study interact with the same binding sites. The PREBIND and LIGAND computer programs were used to analyse the binding data, and the lines corresponding to the fitted parameters were constructed by the CURVMAKE program. The proportion of high-affinity receptors was estimated to be 200% and 440% in the studies shown in (a) and (b) respectively. The two binding sites differed significantly in affinity for fMet-Leu-Phe (affinity ratios of 6.2 and 9.9 respectively; P < 0.005 in each case, partial F test) and fVal-Leu-Phe (affinity ratio of 5.6; P < 0.005), but not for fMetLeu-Phe-NHBzl (affinity ratio of 1.6; P > 0.1).
-equal affinity for binding of f[35S]Met-Leu-Phe to both classes of binding sites ( Table 1 ). The different binding pattern for this analogue compared with the less potent compounds was readily apparent from its much steeper competition curve (Fig. lb) .
The equilibrium dissociation constant (Ku) for high-affinity binding had a range of 1300-fold between the least potent (fValLeu-Phe) and the most potent (fMet-Leu-Phe-Phe) of the seven formyl peptide analogues, whereas the Kd for low-affinity binding varied 9700-fold ( Table 1 ). The total binding capacity of the neutrophil, for both classes of sites in an independent two-
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-°- (geometric mean) of these were of the high-affinity class.
Degranulation characteristics Dose-response curves for stimulation of degranulation by each formyl peptide analogue were assessed in association with the receptor-binding studies (using the same neutrophil preparations). All seven analogues induced the same maximal extent of .,-glucosaminidase release, and the dose-response curves were parallel (Fig. 2) . The geometric mean slope of the computerfitted log-logistic dose-response curves was 1.50; this is equivalent to a difference of 19-fold between doses causing responses of 1000 and 90 % of maximal release (compared with an 81-fold difference for receptor binding with a non-cooperative onebinding-site model). The effective dose at half-maximal response (ED50) for degranulation showed a 950-fold difference between Fig. 3 or Fig. 5 ). The maximal migration is the average migration distance (mean+s.E.M.) at the peak of the biphasic chemotactic dose-response curve. For comparison, the migration in the absence of formyl peptide averaged 1.9 + 0.5 ,um. the least potent (fVal-Leu-Phe) and the most potent (fMet-LeuPhe-Phe) analogues ( Table 2) .
Correlation of degranulation with receptor binding
The ED50 values for the degranulation response for the seven analogues were correlated closely with their Kd values for highaffinity binding (Fig. 3a) : the experimental data (logarithmically transformed) did not deviate significantly from a 450 line of best fit (P > 0.5, analysis of covariance). In absolute terms, however, the ED50 for degranulation was consistently slightly lower, by a factor averaging 1.7, than the high-affinity Kd estimate.
For five of the analogues a similar correlation was found between the ED50 for degranulation and the Kd for low-affinity binding, although in this case there was a 14-fold difference in absolute potencies (Fig. 3b) . This correlation, however, did not extend to the two most potent analogues, fMet-Leu-Phe-Phe and fMet-Leu-Phe-NHBzl. The experimental data points for each of the latter analogues deviated substantially from the 450 line of fit through the remaining five data points (P < 0.001 in each case; analysis of covariance).
Characteristics of the chemotactic response
The dose-response patterns for stimulation of chemotaxis were also assessed for each of the seven analogues. The ED50 values for-this response varied only 1O0-fold between the least potent (fVal-Leu-Phe) and the most potent (fMet-Leu-PheNHBzl) analogue. The four weakest compounds in terms of degranulation potency (fMet-Leu-Phe, fNle-Leu-Phe, fNva-LeuPhe and fVal-Leu-Phe) induced the same maximal extent of migration (P > 0.5, analysis of variance; found with both fMet-Leu-Phe-Phe and fMet-Leu-Phe-NHBzl (P < 0.001 and P < 0.005 respectively; Fig. 4 and Table 2 ). In terms of ED50, the latter analogues were only marginally, if.at all, more potent than fMet-Leu-Phe in stimulation of chemotaxis. Tlhe results are from a typical study of chemotaxis induced by fNvaLeu-Phe (El), fMet-Leu-Phe (0) and fMet-Leu-Phe-Phe (M). Each point is the mean + S.E.M. of ten determinations (five fields on each of two filters). The CHEMOTAXIS and CURVMAKE computer programs were used to analyse these data and construct the symmetrical, biphasic, log-logistic dose-response curves that yielded the optimal fits.
The behaviour of fNle-Leu-Phe-Tyr was intermediate between the two more potent and four less potent analogues (Table 2) , although in this case the increase in efficacy (compared with the weakest analogues) was not statistically significant (P > 0.2).
The increase in maximal migration seen with the more potent analogues primarily reflected a greater degree of migration (or improved directionality) by each cell; the proportion of cells migrating was only slightly elevated (averaging 75 % at the peak of the dose-response curve for fMet-Leu-Phe-Phe compared with 55 % for fVal-Leu-Phe).
Correlation of chemotaxis with receptor binding
The high-or low-affinity binding (Fig. 5 ). This is a somewhat unsatisfactory comparison, however, in view of the different chemotactic efficacies of some analogues. If the comparison is restricted to the four analogues of similar efficacy (those of lowest potency), the ED50 estimates correlated well with both high-and low-affinity Kd values: on average, the ED50 for stimulation of chemotaxis was lower by a factor of about 4.6 than the Kd for high-affinity binding, and it was about 38-fold lower than the Kd for low-affinity binding. In contrast, for the two most potent analogues, fMet-Leu-Phe-Phe and fMet-LeuPhe-NHBzl, the ED50 for the chemotactic response approximately equalled the Kd for high-affinity binding.
DISCUSSION
The present observations confirmed the functional heterogeneity of the binding of chemotactic formyl peptides to their receptors on the rabbit neutrophil [12] , and extended this pattern to analogues of much lower potency than the prototypical compound fMet-Leu-Phe. This pattern ofheterogeneous binding, however, did not extend to the two most potent analogues (fMetLeu-Phe-Phe and fMet-Leu-Phe-NHBzl). The finding of functional heterogeneity suggests the existence of high-and lowaffinity forms of receptor; different models postulate that these forms are either distinct, totally independent receptor classes of fixed affinity [18] , or interconvertible states of a single receptor [15, 16] . Two models of interconvertibility have been proposed: the ternary complex [16] and negative co-operativity [15] models. The present analysis utilized a model of independent receptors of fixed affinity [18] , although the sole basis for choosing this model was its amenability to a thorough and complete mathematical evaluation. The binding data for all seven formyl peptides were consistent with this model; typically, 170% of the total cell complement of receptors were of the high-affinity class and the remaining 83 % of low affinity; these two receptor classes generally differed about 10-fold in their affinity for most chemotactic formyl peptides, but did not differ in affinity for the two most potent analogues ( Table 1) .
Comparison of the binding and degranulation data revealed a good correlation between the Kd values for the high-affinity site and the ED50 estimates for the latter response (Fig. 3a) . A much worse correlation was found with the low-affinity Kd values (Fig.  3b) . The logical interpretation of these data is thus that the highaffinity sites are the receptors that initiate degranulation. The slope of the degranulation dose-response curves (log-logistic slope factor of 1.50) also implies the presence of only a limited number of 'spare receptors'; this is consistent with a primary role for the high-affinity sites in initiating degranulation. (The 1.7-fold receptor excess implied by the ratio of the high-affinity K,, value to the biological ED50 should correspond to a slope factor of 1.52, whereas a slope factor of 1.95 would be expected if the low-affinity sites govern degranulation.) The present results thus contrast with those of earlier studies involving pharmacological manipulations of neutrophil behaviour [19] [20] [21] . Those earlier studies suggested that the low-affinity receptors (or the low-affinity state) might initiate some neutrophil functions, including degranulation. Those studies are difficult to interpret, however, because the treatments to which the neutrophils were subjected (ethanol, antibiotics, dithiothreitol) are by no means specific; they could, through an effect on plasma membrane fluidity, influence the biochemical pathways at several steps beyond the receptor [34] [35] [36] [37] , as well as at this step. This comparison between receptor-binding and biological data may be influenced by two factors that are intrinsic to all such comparisons: the need to perform the assays at different temperatures, and the difference in the temporal nature of these processes. Data from other studies, however, imply that neither factor should invalidate the comparison. The present binding studies were performed at 4°C because receptor processing complicates interpretation of studies on intact cells at 37°C [28, 38, 39] . Studies on isolated plasma membranes, however, have shown the binding pattern and Kd estimates for fMet-Leu-Phe to be little affected by temperature [40] , and to be similar to those found with intact neutrophils at 4°C [5, 10] . Furthermore, Sklar et al. have shown the one-way dissociation rate constants to be similar for formyl peptide agonists of widely differing potencies [41] ; differences in the equilibrium Kd values thus closely reflect differences in the one-way association rate constants that govern the initial binding rate.
The four weakest compounds studied (fMet-Leu-Phe, fNleLeu-Phe, fNva-Leu-Phe and fVal-Leu-Phe) induced a chemotactic response at lower doses than those at which they induced a degranulation response, as previously reported for many formyl peptide agonists [1, 22, 42] . In contrast, the two most potent compounds (fMet-Leu-Phe-Phe and fMet-Leu-Phe-NHBzl) showed slightly higher ED50 values for stimulation of chemotaxis than of degranulation. These two most potent analogues thus displayed three anomalies compared with the less potent analogues: a homogeneous receptor-binding pattern (Fig. lb and Table 1 ), a greater maximal extent of stimulated migration (greater efficacy; Fig. 4 ) and a lower chemotactic potency (higher ED50) than expected from the degranulation potency (Table 2) . Two other groups have also shown increased chemotactic efficacy for very potent chemotactic formyl tetrapeptides [43, 44] . The third most potent analogue in the present study (fNle-Leu-PheTyr) also tended to show the same anomalies, albeit to a much lesser degree. These anomalies for the potent analogues cannot be reconciled with an independent two-binding-site model with receptors offixed affinity; an alternative model ofinterconvertible affinity states thus appears more appropriate. It is probable, moreover, that the anomalies in chemotactic response are related to the anomaly in binding. The lack of any corresponding anomalies in the degranulation response is presumably related to the different nature of this response, most likely to its rapidity [45, 46] compared with the prolonged time course of the chemotactic response [47, 48] . Although the latter response requires receptor recycling [49, 50] , it is unlikely, in view of the differences in binding patterns in the absence of recycling (at 4°C), that the anomalies in this response are due solely to anomalous recycling of receptors occupied by the potent analogues.
Although the present binding data did not show any significant deviations from an independent two-binding-site model with receptors of fixed affinity, this could be related to the low power of the statistical test used to assess such deviations (judged by a deterioration of the fit to the corresponding fMet-Leu-Phe selfcompetition curve [25] ). The present study did, in fact, provide suggestive evidence that a model with a fixed proportion of highaffinity sites was not appropriate, in that the estimated proportion of these sites (geometric mean of 30%) in the competitive binding studies that included one of the most potent analogues (fMet-Leu-Phe-Phe or fMet-Leu-Phe-NHBzl) was greater than the estimate (13 %) from studies that included only weaker analogues. Moreover, individual (unconstrained) analysis of binding data for fNle-Leu-Phe-Tyr suggested that this formyl peptide, the next most potent, might also bind to a greater proportion of high-affinity sites [12] . In conjunction with the anomalies in the biological responses, these results strongly favour a model of interconvertible affinity states over one with fixed states. Such a model can, moreover, explain the present observations (Fig. 6 ). Binding of a formyl peptide agonist to the receptor causes its conversion to a high-affinity state and triggers an immediate signal for degranulation; this biological response thus parallels high-affinity binding. When the agonist is a less potent formyl peptide (such as fMet-Leu-Phe), this activated state is maintained only for a short time; a rapid transition occurs to a lower-affinity state incapable of sustaining a chemotactic signal (Fig. 6a) . This transition does not affect the degranulation signal, but restricts the longer-duration signal for the chemotactic response; migration is thus limited. The most potent analogues (such as fMet-Leu-Phe-Phe), in contrast, stabilize the activated high-affinity state in some way, thereby providing a longer duration signal and greater migration. As a result of its short duration, the signal from the less potent formyl peptides may, at relatively low receptor occupancy, saturate a subsequent step in the biochemical pathway leading to the chemotactic response. It is postulated, however, that such saturation does not occur with the signal of longer duration from the most potent analogues (Fig. 6a) . Through the concept of spare receptors [51, 52] , such a pattern could explain the lower ED50 than Kd values for the less potent, but not the most potent, analogues. This conceptual model is thus in accord with all of the present data.
It is important to relate this conceptual model to the underlying biochemical processes. Other studies provide compelling evidence that a guanine-nucleotide-binding regulatory protein (G-protein)
Vol. 276 transduces the formyl peptide signal from the receptor to the appropriate effector (presumed to be a phosphatidylinositolspecific phospholipase C) [2, 4, 7, 11, 40, [53] [54] [55] . It Fig. 6b ) that undergoes a transition to a high-affinity state (receptor-G-protein complex; state II) upon agonist binding. A three-way fragmentation of the complex is then thought to occur (yielding state IV), separating the receptor, G. and G#Y components; the released G. subunit interacts with the effector, causing cellular activation.
This particular mechanism provides no scope for a liganddependent activated state. Thermodynamic considerations, however, argue against the three-way fragmentation step and imply that some form of intermediate (a complex of either receptor-Gfy or receptor-G,) must occur [58] . The scheme in Fig. 6(b) incorporates such an intermediate (state III), and represents a feasible biochemical counterpart to the conceptual model (Fig.  6a) . The receptor and its associated G-protein are considered to exist in four different states (Fig. 6b) , two of high ligand-binding affinity (II and III). Binding of any agonist to the receptor drives the equilibrium from its resting state (a balance between states I and II, with state I predominant) towards the high-affinity activated state III. The most potent formyl peptides (fMet-LeuPhe-Phe and fMet-Leu-Phe-NHBzl) temporarily stabilize and maintain this activated state, whereas the less potent analogues allow the reaction to proceed readily to a second, low-affinity, activated state (IV). State IV is regarded as transient; state III thus makes the dominant contribution to the overall activation and determines the signal for chemotaxis. Only the initial activation of the G-protein, however, is considered to determine the rapid signal for degranulation, its duration being limited by some subsequent process; this response is unaffected by the stabilization (or otherwise) of state III. This biochemical model thus incorporates the salient features of the conceptual model (Fig. 6a) , particularly the idea that differential stabilization of the activated state III by different agonists may explain the increased chemotactic efficacy of the most potent formyl peptides.
The most important feature of this model is the concept of agonist-dependent stabilization of an activated receptor state (III). As the degree of stabilization of this state may depend on the particular ligand bound to the receptor, the model provides an explanation for the different properties of full and partial agonists. In addition, an antagonist can be regarded in this context as a ligand that binds to the receptor but completely destabilizes the activated state. These features of the model may have much broader applicability beyond the chemotactic formyl peptide receptors in the neutrophil.
There are several parallels between the model proposed in this study and the mechanism for neutrophil activation put forward by Sklar and his colleagues [2, 17, 41, 48, 61] . On the basis of competitive kinetic studies with a fluoresceinated ligand, the latter investigators have reported different residence times at the receptor for full agonists, partial agonists and antagonists, with the full agonists showing the longest residence [41] . Our proposals for the high-affinity activated state III promoted by full and partial agonists are closely analogous.
In conclusion, most chemotactic formyl peptides bind to their neutrophil receptors in a heterogeneous manner, but those of greatest potency show a homogeneous binding pattern. The relative potencies of a series of formyl peptide analogues for stimulation of degranulation correlate well with their potencies for high-affinity, but not low-affinity, binding. The complexity in the patterns for stimulation of chemotaxis cannot be explained by a model comprising two (or more) independent sets of receptors of fixed affinity; instead, a model comprising interconvertible states of different affinities is required. 
